封面
市場調查報告書
商品編碼
1654146

醫藥第三方物流市場規模、佔有率、趨勢分析報告:按產品、溫度、治療領域、製造商規模、服務、地區、細分預測,2025-2030 年

Pharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report By Product, By Temperature, By Therapeutic Area, By Manufacturer Size, By Service, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

醫藥第三方物流市場的成長與趨勢:

根據Grand View Research, Inc.的最新報告,到2030年全球醫藥第三方物流市場規模預計將達到2,285.4億美元,2025年至2030年期間的複合年成長率為8.95%。

由於生技藥品和基因療法等新治療方法的出現,嚴格的監管環境和與藥品分銷相關的日益增加的挑戰推動了這個市場的發展。這種複雜性需要許多製藥公司內部缺乏的物流專業知識,促使他們將物流功能外包給第三方物流供應商,以便專注於研發等核心競爭力。

此外,溫控物流需求的不斷成長也是推動市場成長的因素之一。一些藥物,特別是生技藥品和疫苗,需要從生產到分銷的整個供應鏈中進行溫度控制。因此,需要專門的低溫運輸能力來確保這些溫度敏感產品的完整性和效力。這些因素使得對擁有專業知識和基礎設施以在整個分銷過程中維持必要溫度條件的第三方物流供應商的需求更大。

此外,技術進步也大大改變了醫藥物流格局。區塊鏈、物聯網 (IoT) 和人工智慧 (AI) 等最尖端科技的融合正在徹底改變供應鏈可視性、增強庫存控制並實現對貨物的即時追蹤和監控。這些技術創新使第三方物流供應商能夠最佳化物流業務、降低風險並及時有效地將藥品送到患者手中。

醫藥第三方物流市場的主要企業正在策略性地投資擴大其全球影響力、加強其低溫運輸能力並整合先進技術,以保持競爭力並滿足製藥業不斷變化的需求。全球醫藥供應鏈日益複雜以及溫度敏感產品運輸量的增加,促使第三方物流供應商加強低溫運輸物流基礎設施。這些投資主要集中在建立最先進的設施,包括溫控倉儲和冷藏運輸,以確保敏感醫藥產品的安全有效地運送。例如,DHL供應鏈於2024年2月宣布將投資2億美元擴大其生命科學和醫療物流業務。此項投資將增強 DHL 處理溫度敏感型醫藥產品的能力,並改善低溫運輸物流和合規性。

醫藥第三方物流市場報告重點

  • 就產品類型而言,由於配方的進步和創新治療方法的增加,品牌藥物在市場上佔據主導地位。製藥公司不斷開發針對複雜疾病的標靶治療,促進了該領域的發展。
  • 依溫度分類,2024年常溫佔據最大的市場佔有率。這是因為很多藥物不需要溫控環境來儲存和運輸。
  • 根據治療領域,腫瘤學在 2024 年佔據最大的市場佔有率。由於全球癌症發病率不斷上升以及對包括生物製藥和標靶治療在內的專門治療的需求不斷成長,該領域的市場預計將擴大。
  • 根據製造商規模,大型公司在 2024 年佔據最大的市場佔有率。這主要歸功於我們擁有充足的財務資源來投資大規模的生產能力、廣泛的分銷網路和先進的物流解決方案。
  • 按服務分類,倉儲和航運在 2024 年佔據最大的市場佔有率。這是因為迫切需要安全、可靠的儲存和高效的運輸藥品,包括對溫度敏感的藥品。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章。

  • 細分儀表板
  • 醫藥第三方物流(3PL) 服務市場:產品差異分析
  • 2018 年至 2030 年醫藥第三方物流(3PL) 服務規模及趨勢分析(依產品)
  • 品牌
  • 非專利的
  • 生物相似藥
  • 疫苗
  • 細胞療法
  • 基因治療
  • 其他

第5章:醫藥第三方物流(3PL) 服務市場:溫度估計與趨勢分析

  • 細分儀表板
  • 醫藥第三者物流(3PL) 服務市場:溫度波動分析
  • 2018 年至 2030 年按溫度分類的醫藥第三方物流(3PL) 服務規模與趨勢分析
  • 環境的
  • 冷藏
  • 冷凍
  • 超冷凍/冷凍
  • 低溫

第6章 醫藥第三方物流(3PL) 服務市場:治療領域估計與趨勢分析

  • 細分儀表板
  • 醫藥第三方物流(3PL) 服務市場:治療領域變化分析
  • 2018 年至 2030 年按治療領域分類的醫藥第三方物流(3PL) 服務規模與趨勢分析
  • 腫瘤學
  • 心血管疾病
  • 感染疾病
  • 神經病學
  • 糖尿病
  • 腎臟科
  • 風濕病學
  • 過敏/氣喘
  • 胃腸病學
  • 眼科
  • 其他

第7章 醫藥第三方物流(3PL) 服務市場:製造商規模估計與趨勢分析

  • 細分儀表板
  • 醫藥第三方物流(3PL)服務市場:製造商規模變化分析
  • 2018 年至 2030 年醫藥第三方物流(3PL) 服務規模及趨勢分析(依製造商規模)
  • 大的
  • 中等的
  • 小的

第 8 章:醫藥第三方物流(3PL) 服務市場:服務評估與趨勢分析

  • 細分儀表板
  • 醫藥第三方物流(3PL) 服務市場:服務波動分析
  • 2018 年至 2030 年醫藥第三方物流(3PL) 服務規模與趨勢分析(依服務分類)
  • 儲存和運輸
  • 從訂單到現金
  • 標題 型號
  • DSCSA 和序列化服務
  • 藥品樣品
  • 其他

第9章 區域經營分析

  • 區域控制面板
  • 2018 年至 2030 年市場規模、預測與趨勢分析
  • 北美洲
    • 2018 年至 2030 年北美醫藥第三者物流市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018 年至 2030 年歐洲醫藥第三方物流市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018 年至 2030 年亞太地區醫藥第三方物流市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018 年至 2030 年拉丁美洲醫藥第三方物流市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018 年至 2030 年中東及非洲醫藥第三方物流市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 公司分類
  • 2024 年企業市場分析
  • 公司簡介
    • CEVA Logistics
    • Cencora Corporation(ICS)
    • DB SCHENKER
    • Kuehne+Nagel
    • Kerry Logistics Network Limited
    • Cardinal Health
    • McKesson Corporation
    • EVERSANA.
    • Thermo Fisher Scientific Inc.
    • Knipper Health
Product Code: GVR-4-68040-495-4

Pharmaceutical Third-Party Logistics Market Growth & Trends:

The global pharmaceutical third-party logistics market is expected to reach USD 228.54 billion by 2030, expanding at a CAGR of 8.95% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven due to stringent regulatory landscapes, and the emergence of novel therapies like biologics and gene therapies which have increased the challenges associated with drug distribution. This complexity requires specialized logistics expertise that many pharmaceutical companies lack internally, encouraging them to outsource logistics functions to 3PL providers to concentrate on their core competencies, such as research and development.

Furthermore, growing demand for temperature-controlled logistics is also one of the factors driving market growth. Several pharmaceutical products, particularly biologics and vaccines, demand temperature control throughout the entire supply chain, from manufacturing to the point of delivery. Thus, to ensure the integrity and efficacy of these temperature-sensitive products necessitates specialized cold chain capabilities. These factors are further driving the demand for 3PL providers with the expertise and infrastructure to maintain the required temperature conditions throughout the entire distribution process.

In addition, technological advancements are also transforming the pharmaceutical logistics landscape. The integration of cutting-edge technologies such as blockchain, the Internet of Things (IoT), and artificial intelligence (AI) is revolutionizing supply chain visibility, enhancing inventory management, and enabling real-time tracking and monitoring of shipments. These technological innovations empower 3PL providers to optimize logistics operations, minimize risks, and ensure timely and efficient delivery of pharmaceuticals to patients.

Key players in the pharmaceutical 3PL market are strategically investing in expanding their global presence, enhancing their cold chain capabilities, and integrating advanced technologies to maintain a competitive edge and meet the evolving demands of the pharmaceutical industry. The increasing complexity of global pharmaceutical supply chains and the rise in the transportation of temperature-sensitive products, have prompted 3PL providers to strengthen their cold chain logistics infrastructure. These investments focus on establishing state-of-the-art facilities, such as temperature-controlled warehouses and refrigerated transport, to ensure the safe and effective delivery of sensitive drugs. For instance, in February 2024, DHL supply chain announced to invest USD 200 million which aims to expand life sciences and healthcare logistics operations. This investment will enhance DHL's capabilities in handling temperature-sensitive pharmaceutical products, improving cold chain logistics and compliance.

Pharmaceutical Third-Party Logistics Market Report Highlights:

  • Based on Product, branded dominated the market due to advancements in drug formulations and the increasing availability of innovative therapies. Pharmaceutical companies are constantly developing targeted treatments for complex diseases which are contributing to the segment growth.
  • Based on the temperature, ambient held the largest market share in 2024, as a wide range of pharmaceutical products do not require temperature-controlled environments for storage and transportation.
  • Based on the therapeutic area, oncology held the largest market share in 2024. The market for the segment is projected to expand due to the increasing prevalence of cancer worldwide and the growing demand for specialized treatments, including biologics and targeted therapies.
  • Based on the manufacturer size, large held the largest market share in 2024. This is primarily due to their extensive production capabilities, larger distribution networks, and greater financial resources to invest in advanced logistics solutions.
  • Based on the service, storage and shipping held the largest market share in 2024. This is due to the critical need for secure, reliable storage and efficient transportation of pharmaceutical products, including temperature-sensitive drugs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Temperature Segment
    • 1.2.3. Therapeutic Area Segment
    • 1.2.4. Manufacturer Size Segment
    • 1.2.5. Service Segment
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. The Rise of E-Commerce
      • 3.3.1.2. Growing Demand for Outsourcing Services
      • 3.3.1.3. Rising Demand for Cold Chain Logistics
      • 3.3.1.4. Growing Applications of Reverse Logistics in Biopharmaceutical Industry
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High Operational Costs
      • 3.3.2.2. Compliance Issues While Outsourcing
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
    • 3.4.2. PESTEL Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Third-Party Logistics (3PL) Services Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Product Movement Analysis
  • 4.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Branded
    • 4.4.1. Branded market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Generic
    • 4.5.1. Generic market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Biosimilar
    • 4.6.1. Biosimilar market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Vaccine
    • 4.7.1. Vaccine market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Cell Therapy
    • 4.8.1. Cell therapy market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Gene Therapy
    • 4.9.1. Gene therapy market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Pharmaceutical Third-Party Logistics (3PL) Services Market: Temperature Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Temperature Movement Analysis
  • 5.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Temperature, 2018 to 2030 (USD Million)
  • 5.4. Ambient
    • 5.4.1. Ambient market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Refrigerated
    • 5.5.1. Refrigerated market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Frozen
    • 5.6.1. Frozen market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Ultra-frozen/Deep-Frozen
    • 5.7.1. Ultra-frozen/Deep-Frozen market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Cryogenic
    • 5.8.1. Cryogenic market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Pharmaceutical Third-Party Logistics (3PL) Services Market: Therapeutic Area Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Therapeutic Area Movement Analysis
  • 6.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Cardiovascular Diseases
    • 6.5.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Infectious Diseases
    • 6.6.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Neurology
    • 6.7.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Diabetes
    • 6.8.1. Diabetes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Nephrology
    • 6.9.1. Nephrology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.10. Rheumatology
    • 6.10.1. Rheumatology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.11. Allergy/Asthma
    • 6.11.1. Allergy/Asthma market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.12. Gastroenterology
    • 6.12.1. Gastroenterology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.13. Ophthalmology
    • 6.13.1. Ophthalmology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.14. Others
    • 6.14.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Pharmaceutical Third-Party Logistics (3PL) Services Market: Manufacturer Size Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Manufacturer Size Movement Analysis
  • 7.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Manufacturer Size, 2018 to 2030 (USD Million)
  • 7.4. Large
    • 7.4.1. Large market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Medium
    • 7.5.1. Medium market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Small
    • 7.6.1. Small market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Pharmaceutical Third-Party Logistics (3PL) Services Market: Service Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Service Movement Analysis
  • 8.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 8.4. Storage and Shipping
    • 8.4.1. Storage and Shipping market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Order-to-cash
    • 8.5.1. Order-to-cash market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Title Model
    • 8.6.1. Title Model market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. DSCSA and Serialization Services
    • 8.7.1. DSCSA and Serialization Services market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Pharmaceutical Sampling
    • 8.8.1. Pharmaceutical Sampling market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. Others
    • 8.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. Germany Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.3. UK
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. UK Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. South Korea Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.6. Australia
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. Australia Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.7. Thailand
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. Thailand Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Company Market Position Analysis, 2024
  • 10.3. Company Profiles
    • 10.3.1. CEVA Logistics
      • 10.3.1.1. Company overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Service benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. Cencora Corporation (ICS)
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Service benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. DB SCHENKER
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Service benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. Kuehne+Nagel
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Service benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Kerry Logistics Network Limited
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Service benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Cardinal Health
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Service benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. McKesson Corporation
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Service benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. EVERSANA.
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Service benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Thermo Fisher Scientific Inc.
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Service benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Knipper Health
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Service benchmarking
      • 10.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 5 Global Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 6 Global Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 7 Global Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 8 Global Pharmaceutical Third-party Logistics (3PL) Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 12 North America Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 13 North America Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 14 North America Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 15 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 17 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 18 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 19 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 20 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 22 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 23 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 24 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 25 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 27 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 28 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 29 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 30 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 33 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 34 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 35 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 36 UK Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 37 UK Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 38 UK Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 39 UK Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 40 UK Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 41 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 43 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 44 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 45 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 46 France Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 France Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 48 France Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 49 France Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 50 France Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 51 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 53 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 54 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 55 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 56 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 58 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 59 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 60 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 61 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 63 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 64 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 65 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 66 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 68 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 69 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 70 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 71 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 73 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 74 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 75 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 81 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 82 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 83 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 84 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 85 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 86 China Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 87 China Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 88 China Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 89 China Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 90 China Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 91 India Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 92 India Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 93 India Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 94 India Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 95 India Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 96 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 98 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 99 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 100 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 101 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 102 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 103 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 104 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 105 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 106 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 107 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 108 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 109 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 110 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 111 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
  • Table 112 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 113 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 114 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 115 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 116 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 117 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 118 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 119 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 120 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 121 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 123 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 124 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 125 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 126 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
  • Table 127 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 128 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 129 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 130 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 131 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 132 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 133 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 134 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 135 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 137 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 141 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 142 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 143 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 144 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 145 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 146 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 147 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 148 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Pharmaceutical Third-party Logistics (3PL) Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Pharmaceutical Third-party Logistics (3PL) Market: Product Key Takeaways
  • Fig. 14 Global Pharmaceutical Third-party Logistics (3PL) Market: Product Movement Analysis
  • Fig. 15 Global Pharmaceutical Third-party Logistics (3PL) Market, for Branded, 2018 - 2030 (USD Million)
  • Fig. 16 Global Pharmaceutical Third-party Logistics (3PL) Market, for Generic, 2018 - 2030 (USD Million)
  • Fig. 17 Global Pharmaceutical Third-party Logistics (3PL) Market, for Biosimilar, 2018 - 2030 (USD Million)
  • Fig. 18 Global Pharmaceutical Third-party Logistics (3PL) Market, for Vaccine, 2018 - 2030 (USD Million)
  • Fig. 19 Global Pharmaceutical Third-party Logistics (3PL) Market, for Cell Therapy, 2018 - 2030 (USD Million)
  • Fig. 20 Global Pharmaceutical Third-party Logistics (3PL) Market, for Gene Therapy, 2018 - 2030 (USD Million)
  • Fig. 21 Global Pharmaceutical Third-party Logistics (3PL) Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 22 Global Pharmaceutical Third-party Logistics (3PL) Market: Temperature Key Takeaways
  • Fig. 23 Global Pharmaceutical Third-party Logistics (3PL) Market: Temperature Movement Analysis
  • Fig. 24 Global Pharmaceutical Third-party Logistics (3PL) Market, for Ambient, 2018 - 2030 (USD Million)
  • Fig. 25 Global Pharmaceutical Third-party Logistics (3PL) Market, for Refrigerated, 2018 - 2030 (USD Million)
  • Fig. 26 Global Pharmaceutical Third-party Logistics (3PL) Market, for Frozen, 2018 - 2030 (USD Million)
  • Fig. 27 Global Pharmaceutical Third-party Logistics (3PL) Market, for Ultra-frozen/Deep-Frozen, 2018 - 2030 (USD Million)
  • Fig. 28 Global Pharmaceutical Third-party Logistics (3PL) Market, for Cryogenic, 2018 - 2030 (USD Million)
  • Fig. 29 Global Pharmaceutical Third-party Logistics (3PL) Market: Therapeutic Area Key Takeaways
  • Fig. 30 Global Pharmaceutical Third-party Logistics (3PL) Market, Therapeutic Area Movement Analysis
  • Fig. 31 Global Pharmaceutical Third-party Logistics (3PL) Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 32 Global Pharmaceutical Third-party Logistics (3PL) Market, for cardiovascular diseases, 2018 - 2030 (USD Million)
  • Fig. 33 Global Pharmaceutical Third-party Logistics (3PL) Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 34 Global Pharmaceutical Third-party Logistics (3PL) Market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 35 Global Pharmaceutical Third-party Logistics (3PL) Market, for Diabetes, 2018 - 2030 (USD Million)
  • Fig. 36 Global Pharmaceutical Third-party Logistics (3PL) Market, for Nephrology, 2018 - 2030 (USD Million)
  • Fig. 37 Global Pharmaceutical Third-party Logistics (3PL) Market, for Rheumatology, 2018 - 2030 (USD Million)
  • Fig. 38 Global Pharmaceutical Third-party Logistics (3PL) Market, for Allergy/Asthma, 2018 - 2030 (USD Million)
  • Fig. 39 Global Pharmaceutical Third-party Logistics (3PL) Market, for Gastroenterology, 2018 - 2030 (USD Million)
  • Fig. 40 Global Pharmaceutical Third-party Logistics (3PL) Market, for Ophthalmology, 2018 - 2030 (USD Million)
  • Fig. 41 Global Pharmaceutical Third-party Logistics (3PL) Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 42 Global Pharmaceutical Third-party Logistics (3PL) Market: Manufacturer Size Key Takeaways
  • Fig. 43 Global Pharmaceutical Third-party Logistics (3PL) Market, Manufacturer Size Movement Analysis
  • Fig. 44 Global Pharmaceutical Third-party Logistics (3PL) Market, for Large, 2018 - 2030 (USD Million)
  • Fig. 45 Global Pharmaceutical Third-party Logistics (3PL) Market, for Medium, 2018 - 2030 (USD Million)
  • Fig. 46 Global Pharmaceutical Third-party Logistics (3PL) Market, for Small, 2018 - 2030 (USD Million)
  • Fig. 47 Global Pharmaceutical Third-party Logistics (3PL) Market: Service Key Takeaways
  • Fig. 48 Global Pharmaceutical Third-party Logistics (3PL) Market, Service Movement Analysis
  • Fig. 49 Global Pharmaceutical Third-party Logistics (3PL) Market, for Storage and Shipping, 2018 - 2030 (USD Million)
  • Fig. 50 Global Pharmaceutical Third-party Logistics (3PL) Market, for Order-to-cash, 2018 - 2030 (USD Million)
  • Fig. 51 Global Pharmaceutical Third-party Logistics (3PL) Market, for Title Model, 2018 - 2030 (USD Million)
  • Fig. 52 Global Pharmaceutical Third-party Logistics (3PL) Market, for DSCSA and Serialization Services, 2018 - 2030 (USD Million)
  • Fig. 53 Global Pharmaceutical Third-party Logistics (3PL) Market, for Pharmaceutical Sampling, 2018 - 2030 (USD Million)
  • Fig. 54 Global Pharmaceutical Third-party Logistics (3PL) Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 55 Regional Marketplace: Key Takeaways
  • Fig. 56 Regional Outlook, 2024 & 2030
  • Fig. 57 North America Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 58 Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 59 Canada Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 61 Europe Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 62 Germany Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 63 UK Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 64 France Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 65 Italy Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 66 Spain Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 67 Denmark Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 68 Sweden Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 69 Norway Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 70 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 71 Japan Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 72 China Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 73 India Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 74 Australia Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 75 South Korea Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 76 Thailand Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 77 Latin America Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 79 Argentina Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 80 Middle East and Africa Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 81 South Africa Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 83 UAE Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 84 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)